Professor Michel Haïssaguerre graduated in medicine in 1982 and specialized in cardiology in 1984. He is currently Professor of Cardiology at the University of Bordeaux and heads the Department of Cardiology-electrophysiology at the University Hospital of Bordeaux (Hôpital Cardiologique du Haut-Lévêque).
Dr. Pappone is recognized for his groundbreaking research on new approaches for atrial fibrillation ablation, including developing of new catheter systems, proposing novel ablation approaches and performing remote procedures.
The CABANA Trial is designed to test the hypothesis that left atrial catheter ablation will be superior to drug therapy for decreasing the incidence of the composite endpoint of total mortality, disabling stroke, serious bleeding or cardiac arrest.
Professor of Cardiac Electrophysiology at, Maastricht University
Progressive structural remodeling leads to increased epi-endocardial dissociation, which allows fibrillation waves to propagate between epicardium and endocardium, and become visible as 'breakthrough waves' that contribute to AF stability.
Director of Cardiology and Intensive Care Medicine at St Vincenz Hospital Paderborn
He has a valuable expertise as member and leader of international working groups: ESC Task Force for Atrial Fibrillation 2010; European Heart Rhythm Association (EHRA); EUTRAF and Deutsche Gesellschaft für Kardiologie, among other.
Brent D. Wilson, M.D., Ph.D., has appointments in the Division of Cardiology and in the Department of Radiology at the University of Utah. He serves as Director of the Cardiovascular Center, Director of Cardiology Clinical services and the Advanced Cardiac Imaging Fellowship Program. He has been on faculty at the University of Utah since 2006.
Professor of Bioengineering, University of Utah. Co-founder and Associate Director of the Scientific Computing and Imaging Institute
His area of expertise involves a broad range of techniques (scientific computing, image and signal processing, instrumentation, etc.) that are applied in challenging problems such as computational electrocardiography (forward and inverse problems), atrial fibrillation, clinical and experimental research.
Head of the Cardiovascular Division, Stadtisches Klinikum Karlsruhe, Germany
As co-organizer of Atrial Signals 2015, he is once again involved in a new edition of this symposium. His current research activities in clinical electrophysiology are concerning ablation strategies in atrial fibrillation.
Head of Arrhyhtmia Section. Hospital Clinic. Universitat de Barcelona
His research fields include clinical electrophysiology, cardiac resynchronization therapy, basic research of atrial fibrillation in an animal model, and atrial fibrillation ablation. He was secretary of the EHRA from 2011 to 2013.
Head of the electrophysiological laboratory Klinikum Karlsruhe
Armin studied medicine in Germany, France, and U.K. and received the M.D. degree from the University of Mainz, Mainz, Germany in 2004. He worked as a Physician in Cardiology and Electrophysiologist at the German Heart Center, Munich and Klinikum rechts der Isar, Germany. For the years 2006–2008, he received a Fellowship of Electrophysiology from the German Society of Cardiology. Currently, he is Head of the Electrophysiology Department at the Stadtisches Klinikum Karlsruhe, Germany. His research interests are in the ablation strategies in atrial fibrillation. Dr. Luik is a member of the German Association of Cardiology.
Professor of Farmacology in Universitat Complutense de Madrid
He has obtained several national research prices like Galien, Fundación Lilly of preclinical biomedical research and Fundación BBVA to Groups of Scientific Research in Biomedicine (Cardiovascular area). He was member of the Committee for Practice Guidelines of the European Society of Cardiology.
Dr. Malcolm Finlay read Medicine at Oxford and undertook clinical training in London. He was awarded a PhD from UCL. He is now a consultant cardiologist in the Barts Heart Centre, Europe’s largest cardiac centre. He is an award winning innovator and has invented several novel medical technologies and devices and is a member of the European Heart Rhythm Association Innovations Committee.
Professor Department of Cardiac Sciences, Cumming School of Medicine
Adjunct Professor Department of Medicine, Cardiology Division Associate Scientist, Global Health, Neglected Diseases & Arrhythmias Population Health Research Institute-McMaster University David Braley Cardiac Vascular, Hamilton ON Canada
Dr Matteo Anselmino is professor at the University of Turin, in the Surgical Sciences department and he is researcher in cardiology. He is specialist in diabetology, cardiothoracic surgery and internal medicine. He is author of multiple research papers in the field of cardiology.
Head of the Arrhythmias and Robotic Electrophysiology Unit, Hospital Universitario La Paz, Madrid
Dr. Merino has performed over 4,000 ablation procedures as the first operator and has treated the most complex arrhythmias. He has published more than 150 scientific articles, and is author of more than 500 contributions in congresses of Cardiology. Dr. Merino Llorens has been president of the Elecrophysiology and Arrhythmias section of the Spanish Society of Cardiology. Since 2003 he has been an active member of the European Heart Rhythm Association (EHRA) of the ESC. Among other responsabilities, he has been Chairman of the EHRA Certification and Training Fellowship Committees, and he is currently chairman of the EHRA Education Committee.
Dr Junaid Zaman is a cardiology and general medicine specialist registered in the London Deanery and Fulbright British Heart Foundation Scholar at the National Heart and Lung Institute, Imperial College & Stanford University, USA. He received the prestigious inaugural UK-US Fulbright British Heart Foundation Research Scholar Award to continue his postdoctoral fellowship at Stanford University with Dr Sanjiv Narayan, and is currently looking into new methods to study and treat cardiac fibrillation.
Dr Guerra is a cardiologist from the Hospital de la Santa Creu i Sant Pau (Barcelona) and associate profesor in the Medicine department of the Universitat Autònoma de Barcelona. His main research field is the arrhythmias with especial interest in atrial fibrilation.
Dr. Ing. Tobias Oesterlein is a research associate at the Institute of Biomedical Engineering of Karlsuhe (KIT) in Germany, where he works in the project group of medical measurement technology and digital signal processing, in the field of atrial fibrillation.